Jane Street’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $309K | Buy |
+213,396
| New | +$309K | ﹤0.01% | 4275 |
|
2024
Q4 | – | Sell |
-93,876
| Closed | -$468K | – | 6655 |
|
2024
Q3 | $468K | Sell |
93,876
-5,160
| -5% | -$25.7K | ﹤0.01% | 4371 |
|
2024
Q2 | $579K | Sell |
99,036
-54,097
| -35% | -$316K | ﹤0.01% | 4352 |
|
2024
Q1 | $1.22M | Buy |
153,133
+69,511
| +83% | +$552K | ﹤0.01% | 2954 |
|
2023
Q4 | $488K | Buy |
+83,622
| New | +$488K | ﹤0.01% | 4131 |
|
2022
Q3 | – | Sell |
-10,176
| Closed | -$32K | – | 6339 |
|
2022
Q2 | $32K | Buy |
+10,176
| New | +$32K | ﹤0.01% | 5011 |
|
2022
Q1 | – | Sell |
-11,307
| Closed | -$51K | – | 6184 |
|
2021
Q4 | $51K | Buy |
+11,307
| New | +$51K | ﹤0.01% | 4872 |
|